Peptides
Semaglutide's Expanding Map: Beyond Weight Loss to Heart, Skin, and Fat Biology
A wave of 2025 research suggests GLP-1 agonists are doing more than shrinking waistlines — nudging lipid panels, reshaping fat tissue, and edging into cardiology and dermatology. The signal is real, but still moderate.